GREAT POINT PARTNERS LLC 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:37 pm Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | GREAT POINT PARTNERS LLC | 0 0.000% | -6,360,161 (Position Closed) | Filing |
| 2023-04-13 1:58 pm Purchase | 2022-11-02 | 13G | Heron Therapeutics, Inc. HRTX | GREAT POINT PARTNERS LLC | 6,360,161 5.350% | 6,360,161 (New Position) | Filing |